S&P 500   4,283.94 (+0.38%)
DOW   33,745.60 (+0.24%)
QQQ   352.53 (+1.06%)
AAPL   179.18 (+0.76%)
MSFT   325.87 (+0.77%)
META   266.28 (+1.02%)
GOOGL   122.83 (+0.27%)
AMZN   124.82 (+2.96%)
TSLA   232.33 (+3.46%)
NVDA   385.06 (+2.75%)
NIO   7.64 (-1.55%)
BABA   86.69 (+1.65%)
AMD   121.44 (+3.06%)
T   15.93 (-1.06%)
F   13.47 (-0.88%)
MU   65.22 (-2.74%)
CGC   0.70 (-2.55%)
GE   107.19 (+1.05%)
DIS   92.09 (-0.46%)
AMC   4.59 (-2.96%)
PFE   39.04 (+0.39%)
PYPL   64.41 (+0.58%)
NFLX   405.69 (+1.48%)
S&P 500   4,283.94 (+0.38%)
DOW   33,745.60 (+0.24%)
QQQ   352.53 (+1.06%)
AAPL   179.18 (+0.76%)
MSFT   325.87 (+0.77%)
META   266.28 (+1.02%)
GOOGL   122.83 (+0.27%)
AMZN   124.82 (+2.96%)
TSLA   232.33 (+3.46%)
NVDA   385.06 (+2.75%)
NIO   7.64 (-1.55%)
BABA   86.69 (+1.65%)
AMD   121.44 (+3.06%)
T   15.93 (-1.06%)
F   13.47 (-0.88%)
MU   65.22 (-2.74%)
CGC   0.70 (-2.55%)
GE   107.19 (+1.05%)
DIS   92.09 (-0.46%)
AMC   4.59 (-2.96%)
PFE   39.04 (+0.39%)
PYPL   64.41 (+0.58%)
NFLX   405.69 (+1.48%)
S&P 500   4,283.94 (+0.38%)
DOW   33,745.60 (+0.24%)
QQQ   352.53 (+1.06%)
AAPL   179.18 (+0.76%)
MSFT   325.87 (+0.77%)
META   266.28 (+1.02%)
GOOGL   122.83 (+0.27%)
AMZN   124.82 (+2.96%)
TSLA   232.33 (+3.46%)
NVDA   385.06 (+2.75%)
NIO   7.64 (-1.55%)
BABA   86.69 (+1.65%)
AMD   121.44 (+3.06%)
T   15.93 (-1.06%)
F   13.47 (-0.88%)
MU   65.22 (-2.74%)
CGC   0.70 (-2.55%)
GE   107.19 (+1.05%)
DIS   92.09 (-0.46%)
AMC   4.59 (-2.96%)
PFE   39.04 (+0.39%)
PYPL   64.41 (+0.58%)
NFLX   405.69 (+1.48%)
S&P 500   4,283.94 (+0.38%)
DOW   33,745.60 (+0.24%)
QQQ   352.53 (+1.06%)
AAPL   179.18 (+0.76%)
MSFT   325.87 (+0.77%)
META   266.28 (+1.02%)
GOOGL   122.83 (+0.27%)
AMZN   124.82 (+2.96%)
TSLA   232.33 (+3.46%)
NVDA   385.06 (+2.75%)
NIO   7.64 (-1.55%)
BABA   86.69 (+1.65%)
AMD   121.44 (+3.06%)
T   15.93 (-1.06%)
F   13.47 (-0.88%)
MU   65.22 (-2.74%)
CGC   0.70 (-2.55%)
GE   107.19 (+1.05%)
DIS   92.09 (-0.46%)
AMC   4.59 (-2.96%)
PFE   39.04 (+0.39%)
PYPL   64.41 (+0.58%)
NFLX   405.69 (+1.48%)
NYSE:OSH

Oak Street Health (OSH) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
N/A
50-Day Range
$34.57
$39.00
52-Week Range
N/A
Volume
2.86 million shs
Average Volume
5.76 million shs
Market Capitalization
$9.52 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$33.27

Oak Street Health MarketRank™ Forecast

Analyst Rating
Hold
2.06 Rating Score
Upside/​Downside
∞ Upside
$33.27 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
-1.01
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$26.63 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.58) to ($1.12) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.07 out of 5 stars

Medical Sector

920th out of 981 stocks

Health Services Industry

12th out of 13 stocks


OSH stock logo

About Oak Street Health (NYSE:OSH) Stock

Oak Street Health, Inc., together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas. The company was founded in 2012 and is headquartered in Chicago, Illinois.

Receive OSH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oak Street Health and its competitors with MarketBeat's FREE daily newsletter.

OSH Stock News Headlines

The Real Problem With "Made in America" Lithium
Politicians love to say they support "Made in America" when it comes to manufacturing. But when it comes to lithium - the metal fueling our transition to electric vehicles - it's not that simple.
Comparing DocGo (NASDAQ:DCGO) and Oak Street Health (NYSE:OSH)
Reviewing DocGo (NASDAQ:DCGO) & Oak Street Health (NYSE:OSH)
The Real Problem With "Made in America" Lithium
Politicians love to say they support "Made in America" when it comes to manufacturing. But when it comes to lithium - the metal fueling our transition to electric vehicles - it's not that simple.
Oak Street Health (NYSE:OSH) Sets New 1-Year High at $38.87
See More Headlines


OSH Company Calendar

Last Earnings
2/28/2023
Today
6/08/2023
Next Earnings (Estimated)
7/31/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
6,000
Year Founded
2012

Price Target and Rating

Average Stock Price Forecast
$33.27
High Stock Price Forecast
$39.00
Low Stock Price Forecast
$18.00
Consensus Rating
Hold
Rating Score (0-4)
2.06
Research Coverage
17 Analysts

Profitability

Net Income
$-509,200,000.00
Pretax Margin
-23.58%

Debt

Sales & Book Value

Annual Sales
$2.16 billion
Book Value
($1.10) per share

Miscellaneous

Free Float
215,817,000
Market Cap
$9.52 billion
Optionable
Not Optionable
Beta
2.23

Social Links


Key Executives

  • Mr. Michael T. PykoszMr. Michael T. Pykosz (Age 41)
    CEO & Chairman
    Comp: $886.49k
  • Mr. Geoffrey M. PriceMr. Geoffrey M. Price (Age 41)
    Chief Innovation Officer & Director
    Comp: $789.58k
  • Mr. Timothy M. CookMr. Timothy M. Cook
    Chief Financial Officer
  • Mr. Brian Clem (Age 40)
    Chief Operating Officer
    Comp: $587.25k
  • Mr. Robert GuenthnerMr. Robert Guenthner (Age 51)
    Chief Legal Officer & Sec.
    Comp: $492.62k
  • Murali Balakumar
    Chief Information Officer
  • Ms. Sarah Cluck
    Head of Investor Relations
  • Ms. Erica Frank
    VP of PR
  • Ms. Cynthia Hiskes (Age 54)
    Chief HR Officer
  • Dr. Griffin R. Myers M.D. (Age 42)
    Chief Medical Officer of Provider Engagement & Director













OSH Stock - Frequently Asked Questions

Should I buy or sell Oak Street Health stock right now?

17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Oak Street Health in the last twelve months. There are currently 1 sell rating, 14 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" OSH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OSH, but not buy additional shares or sell existing shares.
View OSH analyst ratings
or view top-rated stocks.

What is Oak Street Health's stock price forecast for 2023?

17 brokerages have issued twelve-month target prices for Oak Street Health's shares. Their OSH share price forecasts range from $18.00 to $39.00. On average, they predict the company's share price to reach $33.27 in the next year.
View analysts price targets for OSH
or view top-rated stocks among Wall Street analysts.

When is Oak Street Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, July 31st 2023.
View our OSH earnings forecast
.

How were Oak Street Health's earnings last quarter?

Oak Street Health, Inc. (NYSE:OSH) released its earnings results on Tuesday, February, 28th. The company reported ($0.56) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.58) by $0.02. The firm earned $577.70 million during the quarter, compared to the consensus estimate of $571.26 million. The firm's revenue was up 46.6% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.62) earnings per share.

What is Peter Botten's approval rating as Oak Street Health's CEO?

17 employees have rated Oak Street Health Chief Executive Officer Peter Botten on Glassdoor.com. Peter Botten has an approval rating of 71% among the company's employees.

What other stocks do shareholders of Oak Street Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oak Street Health investors own include Alibaba Group (BABA), Tesla (TSLA), Adobe (ADBE), NVIDIA (NVDA), Okta (OKTA), Zoom Video Communications (ZM), Autodesk (ADSK), Boeing (BA), Lockheed Martin (LMT) and Micron Technology (MU).

When did Oak Street Health IPO?

(OSH) raised $250 million in an initial public offering on Thursday, August 6th 2020. The company issued 15,600,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley acted as the underwriters for the IPO and William Blair, Piper Sandler, Baird and SunTrust Robinson Humphrey were co-managers.

What is Oak Street Health's stock symbol?

Oak Street Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "OSH."

Who are Oak Street Health's major shareholders?

Oak Street Health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Farallon Capital Management LLC (1.85%), Route One Investment Company L.P. (0.79%), Geode Capital Management LLC (0.66%), Davidson Kempner Capital Management LP (0.65%), Schonfeld Strategic Advisors LLC (0.60%) and Glazer Capital LLC (0.54%). Insiders that own company stock include Brian Clem, General Atlantic Llc, Geoffrey M Price, Geoffrey M Price, Griffin Myers, Kim Keck, Michael Robert Martin, Michael T Pykosz, Michael T Pykosz, Newlight Partners Lp, Robert Guenthner, Shawn Henry and Timothy M Cook.
View institutional ownership trends
.

How much money does Oak Street Health make?

Oak Street Health (NYSE:OSH) has a market capitalization of $0.00 and generates $2.16 billion in revenue each year. The company earns $-509,200,000.00 in net income (profit) each year or ($2.21) on an earnings per share basis.

How many employees does Oak Street Health have?

The company employs 6,000 workers across the globe.

Does Oak Street Health have any subsidiaries?
The following companies are subsidiares of Oak Street Health: Acorn Network LLC, Oak Street Health Mso LLC, and RubiconMD.
Read More
How can I contact Oak Street Health?

Oak Street Health's mailing address is 30 W. MONROE ST. STE. 1200, CHICAGO IL, 60603. The official website for the company is www.oakstreethealth.com. The company can be reached via phone at 844-871-5650 or via email at investors@oakstreethealth.com.

This page (NYSE:OSH) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -